NewEdge Wealth LLC Has $1.78 Million Stock Holdings in National Health Investors, Inc. $NHI

NewEdge Wealth LLC raised its stake in National Health Investors, Inc. (NYSE:NHI) by 48.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,054 shares of the real estate investment trust’s stock after purchasing an additional 7,231 shares during the period. NewEdge Wealth LLC’s holdings in National Health Investors were worth $1,783,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. PNC Financial Services Group Inc. boosted its position in shares of National Health Investors by 7.1% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,640 shares of the real estate investment trust’s stock worth $294,000 after purchasing an additional 241 shares in the last quarter. Dimensional Fund Advisors LP increased its position in National Health Investors by 2.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust’s stock valued at $55,493,000 after buying an additional 18,164 shares in the last quarter. Swiss National Bank raised its stake in National Health Investors by 0.7% during the 1st quarter. Swiss National Bank now owns 94,320 shares of the real estate investment trust’s stock worth $7,627,000 after buying an additional 700 shares during the period. Forty three Eighteen Advisors LLC acquired a new position in National Health Investors during the 1st quarter worth approximately $2,005,000. Finally, Assetmark Inc. boosted its holdings in National Health Investors by 13.5% in the first quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock worth $110,000 after acquiring an additional 161 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Down 0.1%

NHI stock opened at $80.49 on Monday. The firm has a market capitalization of $3.90 billion, a PE ratio of 25.96, a P/E/G ratio of 3.62 and a beta of 0.51. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The stock’s 50 day moving average is $75.02 and its 200-day moving average is $79.74.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. Wells Fargo & Company lowered their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Truist Financial cut their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. BMO Capital Markets reduced their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

Insiders Place Their Bets

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction dated Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by insiders.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.